A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoprotein.
Dengue virus (DENV) is a major mosquito-borne pathogen infecting up to 100 million people each year; so far no effective treatment or vaccines are available. Recently, highly cross-reactive and infection-enhancing pre-membrane (prM)-specific antibodies were found to dominate the anti-DENV immune res...
Main Authors: | Annie Hoi Yi Chan, Hwee Cheng Tan, Angelia Yee Chow, Angeline Pei Chiew Lim, Shee Mei Lok, Nicole J Moreland, Subhash G Vasudevan, Paul A MacAry, Eng Eong Ooi, Brendon J Hanson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3317930?pdf=render |
Similar Items
-
Optimized expression of full-length IgG1 antibody in a common E. coli strain.
by: Conrad En Zuo Chan, et al.
Published: (2010-01-01) -
Analysis of PRM1 and PRM2 Polymorphisms in Iranian Infertile Men with Idiopathic Teratozoospermia
by: Fatemeh Dehghanpour, et al.
Published: (2019-04-01) -
Cryptic CTL epitopes derived from antisense transcription are frequently recognized in HIV-1 infection
by: Bansal, A, et al.
Published: (2009) -
Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope.
by: S Kyle Austin, et al.
Published: (2012-01-01) -
Novel lamprey antibody recognizes terminal sulfated galactose epitopes on mammalian glycoproteins
by: Tanya R. McKitrick, et al.
Published: (2021-06-01)